Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,533 | -117,194 | -79,492 | -50,657 | -24,275 |
| Depreciation Amortization | 2,795 | 7,788 | 5,572 | 3,430 | 1,607 |
| Accounts receivable | N/A | -6,000 | 0 | -2,537 | N/A |
| Accounts payable and accrued liabilities | -103 | 1,589 | 727 | 2,119 | 899 |
| Other Working Capital | -8,963 | 9,113 | 9,381 | 17,101 | 28,021 |
| Other Operating Activity | 6,174 | 20,339 | 10,358 | 7,062 | 1,801 |
| Operating Cash Flow | $-42,630 | $-84,365 | $-53,454 | $-23,482 | $8,053 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,472 | -5,661 | -4,799 | -2,934 | -843 |
| Purchase Of Investment | -15,245 | -348,497 | -257,813 | -183,238 | -47,742 |
| Sale Of Investment | 58,748 | 245,907 | 190,884 | 126,675 | 46,198 |
| Investing Cash Flow | $40,031 | $-108,251 | $-71,728 | $-59,497 | $-2,387 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,488 | 153,883 | 153,383 | 151,831 | 1,360 |
| Common Stock Repurchased | N/A | -1 | -1 | -1 | -1 |
| Financing Cash Flow | $1,488 | $153,882 | $153,382 | $151,830 | $1,359 |
| Beginning Cash Position | 80,792 | 119,526 | 119,526 | 119,526 | 119,526 |
| End Cash Position | 79,681 | 80,792 | 147,726 | 188,377 | 126,551 |
| Net Cash Flow | $-1,111 | $-38,734 | $28,200 | $68,851 | $7,025 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,630 | -84,365 | -53,454 | -23,482 | 8,053 |
| Capital Expenditure | -3,472 | -5,661 | -4,799 | -2,934 | -843 |
| Free Cash Flow | -46,102 | -90,026 | -58,253 | -26,416 | 7,210 |